WATERTOWN, Massachusetts—/PRNewswire/—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious eye disorders, today announced 12-month data from the...
LONDON (Newswire.com) - EW Healthcare Partners (“EW”) has acquired a majority stake in Grundium Oy (“Grundium”), a leader in advanced imaging technology based in Finland. The founders and management of Grundium will retain a significant minority stake in the company...
MILAN, Italy—Following the positive outcome of the regulatory clearances process, Recordati announces today the closing of the previously announced acquisition of EUSA Pharma (UK) Ltd(1), a global specialty pharmaceutical company focused on rare and niche oncology...
Series E Financing led by EW Healthcare Partners with Robert S White to Join Board SAN JOSE, California —— VitalConnect®, Inc., a leader in remote and in-hospital wearable biosensor technology, today announced the completion of a $39 million round of financing, funded...
PARIS, France—Laboratoires Majorelle, a fast-growing French specialty pharma company focused on prescription and OTC products in women’s health and urology, today announces the appointment of Alexandre de Germay as Chief Executive Officer. Alexandre de Germay has more...
NEW YORK, New York – EW Healthcare Partners (“EW”), a leading healthcare growth equity firm with a global investment practice, has announced the promotion of senior executives of their investment team. • Brooks Andrews has been promoted to Managing Director; and •...
London, UNITED KINGDOM—EW Healthcare Partners (“EW”) has acquired a majority stake in Laboratoires Majorelle (“Majorelle”) from its Founders to support its growth and European expansion in line with the Founders’ strategy. Headquartered in Paris, Majorelle is a French...
DURHAM, North Carolina –– Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has acquired Bioness, Inc. (“Bioness”), a global leader in neuromodulation and rehabilitation medical devices through its...
WILMINGTON, Mass.—(BUSINESS WIRE)—Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of Cognate BioServices, Inc. for approximately $875 million, subject to customary closing...
